Where can I buy Capmatinib (Capatinib) in 2024? How much? Can it be reimbursed?

Capatinib (Capatinib) is an innovative oral small molecule targeted drug that belongs to the category of tyrosine kinase inhibitors. It specifically targets and inhibits the activity of MET (hepatocyte growth factor receptor) kinase, thereby blocking the growth signaling pathway of tumor cells and achieving the effect of inhibiting tumor proliferation and spread. The drug is mainly used to treat patients with non-small cell lung cancer (NSCLC) carrying METex14 mutations, providing them with a new treatment option. So, for patients who need this medication, how do they purchase it? What's the price? And can I enjoy medical insurance reimbursement? Below is the detailed answer.

1. Purchase channels:

Capmatinib has been approved for marketing in China, but due to its short time, it is difficult for patients to purchase it. Patients in need can purchase through formal overseas channels, and can consult some professional overseas medical institutions for help. Be sure to choose an institution with a good reputation and qualifications.

2. Price situation:

Capmatinib price varies by region, channel and strength. Overseas, the price of the original drug capmatinib is relatively high, with each box (specification: 200mg*56 tablets) costing around tens of thousands of yuan. However, for patients with limited financial conditions, Laotian generic drugs may be a more affordable option, with prices ranging from about three to four thousand yuan. However, please note that factors such as exchange rate fluctuations and transportation costs need to be considered when purchasing drugs overseas.

3. Medical insurance reimbursement:

As of 2024, capmatinib has not yet been included in my country’s medical insurance catalog, so it cannot enjoy medical insurance reimbursement. This is undoubtedly a considerable financial burden for patients who require long-term treatment. However, it is worth noting that as the national medical insurance policy continues to be improved and updated, capmatinib is expected to be included in the medical insurance catalog in the future to reduce financial pressure on patients.

In summary, patients who need to purchase capmatinib should fully understand the drug’s purchase channels, price conditions, and medical insurance reimbursement policies. At the same time, it is recommended to formulate an individualized treatment plan under the guidance of a doctor, and to maintain patience and active cooperation during the treatment process to obtain the best treatment effect. When purchasing medicines, be sure to choose formal channels and reputable merchants to ensure the quality and safety of the medicines.